ATAI Life Sciences N.V (NASDAQ: ATAI) kicked off on Tuesday, down -3.77% from the previous trading day, before settling in for the closing price of $1.59. Over the past 52 weeks, ATAI has traded in a range of $1.03-$2.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -16.02% over the last five years. While this was happening, its average annual earnings per share was recorded -217.14%. With a float of $117.06 million, this company’s outstanding shares have now reached $167.82 million.
The firm has a total of 83 workers. Let’s measure their productivity. In terms of profitability, gross margin is 19.64%, operating margin of -31987.01%, and the pretax margin is -38614.5%.
ATAI Life Sciences N.V (ATAI) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of ATAI Life Sciences N.V is 30.24%, while institutional ownership is 7.14%. The most recent insider transaction that took place on Sep 26 ’24, was worth 16,093,000. In this transaction 10% Owner of this company sold 2,660,000 shares at a rate of $6.05, taking the stock ownership to the 6,905,774 shares. Before that another transaction happened on May 16 ’24, when Company’s insider sold 151,303 for $1.92, making the entire transaction worth $290,502. This insider now owns 328,697 shares in total.
ATAI Life Sciences N.V (ATAI) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -217.14% per share during the next fiscal year.
ATAI Life Sciences N.V (NASDAQ: ATAI) Trading Performance Indicators
Take a look at ATAI Life Sciences N.V’s (ATAI) current performance indicators. Last quarter, stock had a quick ratio of 5.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 778.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of ATAI Life Sciences N.V (ATAI)
Analysing the last 5-days average volume posted by the [ATAI Life Sciences N.V, ATAI], we can find that recorded value of 1.22 million was better than the volume posted last year of 1.21 million. As of the previous 9 days, the stock’s Stochastic %D was 26.55%. Additionally, its Average True Range was 0.14.
During the past 100 days, ATAI Life Sciences N.V’s (ATAI) raw stochastic average was set at 54.35%, which indicates a significant increase from 28.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 70.71% in the past 14 days, which was lower than the 74.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3396, while its 200-day Moving Average is $1.5444. Now, the first resistance to watch is $1.5867. This is followed by the second major resistance level at $1.6433. The third major resistance level sits at $1.6867. If the price goes on to break the first support level at $1.4867, it is likely to go to the next support level at $1.4433. Now, if the price goes above the second support level, the third support stands at $1.3867.
ATAI Life Sciences N.V (NASDAQ: ATAI) Key Stats
The company with the Market Capitalisation of 256.74 million has total of 167,802K Shares Outstanding. Its annual sales at the moment are 310 K in contrast with the sum of -40,220 K annual income. Company’s last quarter sales were recorded 40 K and last quarter income was -26,290 K.
